Kiora Pharmaceuticals's total assets for Q1 2026 were $21.23M, a decrease of -12.48% from the previous quarter. KPRX total liabilities were $7.29M for the fiscal quarter, a -10.27% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.